GPR55 and stroke disorder: With this goal in mind, mice were subjected to tMCAO (1 h occlusion followed by reperfusion), and 6 h after stroke onset, they were injected with IP and 1 μg/mL ML-193, the most potent GPR55 antagonist, or with the vehicle only (0.001% DMSO) as a control, respectively [20,44].